日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Alcelaphine herpesvirus 1 Capsid protein VP23 (26) CSB-YP516601AZG
CSB-EP516601AZG
CSB-BP516601AZG
CSB-MP516601AZG
CSB-EP516601AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Capsid-binding protein 33 (33) CSB-YP516602AZG
CSB-EP516602AZG
CSB-BP516602AZG
CSB-MP516602AZG
CSB-EP516602AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Uncharacterized gene 38 protein (38) CSB-YP516603AZG
CSB-EP516603AZG
CSB-BP516603AZG
CSB-MP516603AZG
CSB-EP516603AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Probable ATP-dependent helicase 44 (44), partial CSB-YP516604AZG
CSB-EP516604AZG
CSB-BP516604AZG
CSB-MP516604AZG
CSB-EP516604AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Uncharacterized gene A8 protein (A8), partial CSB-YP516605AZG1
CSB-EP516605AZG1
CSB-BP516605AZG1
CSB-MP516605AZG1
CSB-EP516605AZG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Helicase/primase complex protein (56), partial CSB-YP516606AZG
CSB-EP516606AZG
CSB-BP516606AZG
CSB-MP516606AZG
CSB-EP516606AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Capsid assembly protein 63 (63), partial CSB-YP516607AZG
CSB-EP516607AZG
CSB-BP516607AZG
CSB-MP516607AZG
CSB-EP516607AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Uncharacterized gene 66 protein (66), partial CSB-YP516608AZG1
CSB-EP516608AZG1
CSB-BP516608AZG1
CSB-MP516608AZG1
CSB-EP516608AZG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alcelaphine herpesvirus 1 Uncharacterized gene 73 protein (73), partial CSB-YP516609AZG
CSB-EP516609AZG
CSB-BP516609AZG
CSB-MP516609AZG
CSB-EP516609AZG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza B virus Polymerase basic protein 2 (PB2), partial CSB-YP516610IMX
CSB-EP516610IMX
CSB-BP516610IMX
CSB-MP516610IMX
CSB-EP516610IMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant African swine fever virus Ankyrin repeat domain-containing protein A238L (Mal-047) CSB-YP516612AYE
CSB-EP516612AYE
CSB-BP516612AYE
CSB-MP516612AYE
CSB-EP516612AYE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Wiseana iridescent virus Major capsid protein (MCP) CSB-YP516613WBN
CSB-EP516613WBN
CSB-BP516613WBN
CSB-MP516613WBN
CSB-EP516613WBN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bean yellow dwarf virus Movement protein (V2), partial CSB-YP516614BSL1
CSB-EP516614BSL1
CSB-BP516614BSL1
CSB-MP516614BSL1
CSB-EP516614BSL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rotavirus A Outer capsid glycoprotein VP7 CSB-YP516615ROE
CSB-EP516615ROE
CSB-BP516615ROE
CSB-MP516615ROE
CSB-EP516615ROE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Faba bean necrotic yellows virus Protein U1 (DNA-U1) CSB-YP516616FEA
CSB-EP516616FEA
CSB-BP516616FEA
CSB-MP516616FEA
CSB-EP516616FEA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human cytomegalovirus Protein UL41A (UL41A), partial CSB-YP516617HWV1
CSB-EP516617HWV1
CSB-BP516617HWV1
CSB-MP516617HWV1
CSB-EP516617HWV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Replication protein E1 (E1), partial CSB-YP516618HXI
CSB-EP516618HXI
CSB-BP516618HXI
CSB-MP516618HXI
CSB-EP516618HXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cucumber mosaic virus Replication protein 1a (ORF1a), partial CSB-YP516619DZH
CSB-EP516619DZH
CSB-BP516619DZH
CSB-MP516619DZH
CSB-EP516619DZH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cucumber mosaic virus Movement protein (ORF3a) CSB-YP516620DZF
CSB-EP516620DZF
CSB-BP516620DZF
CSB-MP516620DZF
CSB-EP516620DZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maize streak virus genotype C Replication-associated protein A (C1) CSB-YP516621MPQ
CSB-EP516621MPQ
CSB-BP516621MPQ
CSB-MP516621MPQ
CSB-EP516621MPQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×